Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...
- Featured Article
How risk-based quality management (RBQM) can harness the power of AI and advanced analytics to transform...
Source: Journal for Clinical Studies
- Press Release
New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing...
- Featured Article
AI is reshaping clinical data management (DM), moving the industry away from time-consuming, inefficient processes and...
Source: PharmaTimes Magazine
- Featured Article
Clinical trials are undergoing a period of change. Innovative uses of artificial intelligence (AI) are unlocking...
Source: Applied Clinical Trials
- Featured Article
Safety reporting is a critical aspect of clinical trial quality, directly impacting patient safety and regulatory...
Source: Applied Clinical Trials
- Featured Article
In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes...
Source: Clinical Research News
- Featured Article
The theme for this year’s International Women’s Day (IWD) on 8th March was ‘Give to Gain’....
Source: Pharmaphorum
- Featured Article
Quality tolerance limits (QTLs) are trial-level thresholds on critical-to-quality (CtQ) factors—key measures where sustained deviation could...
Source: Applied Clinical Trials
- Featured Article
Risk-based quality management (RBQM) is becoming central to clinical trial oversight, with ICH E6(R3) emphasising proportional,...
Source: Discover Pharma
- Featured Article
Analysis of more than 880 clinical trials shows that while statistical data monitoring and key risk...
Source: Applied Clinical Trials
- Press Release
King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM)...
- Press Release
Cambridge, MA – FDA and its stakeholders have an interest in assuring the integrity of clinical...
- Press Release
We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration!...
- Press Release
The CluePoints and OmniComm Risk-Based Monitoring Implementation Roadshow is Coming to a City Near You! In...
- Press Release
We’re thrilled to announce that CluePoints is now offering a complimentary Risk-Based Monitoring strategy Check-up and...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...
- Press Release
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...
- Press Release
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...
- Press Release
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...
- Press Release
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...
- Press Release
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...
- Featured Article
The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a...
Source: Clinical Research News
- Featured Article
Nicolas Huet, CluePoints Machine Learning Manager, discusses developments in the use of machine learning and deep...
Source: Pharmaceutical Outsourcing
- Featured Article
In the fifth and final part of this video interview series, Ken Getz, executive director and...
Source: Applied Clinical Trials
- Featured Article
In part 4 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 3 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 1 of this video interview series with Ken Getz, executive director and research professor,...
Source: Applied Clinical Trials
- Featured Article
We are at a tipping point in the adoption of Clinical Research 2.0. The evolution of...
Source: PM360
- Featured Article
In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...
Source: Applied Clinical Trials
- Featured Article
Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...
Source: Springer Link
- Featured Article
We spoke with leaders and experts in the Clinical Research community about their predictions for 2024.
...Source: Clinical Research News
- Featured Article
Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable...
Source: Applied Clinical Trials